Close search

Evidence Based Benzodiazepine Tapering: 2025 ASAM Guidelines in Practice

View course details
Evidence-Based Clinical Course
Evidence-Based Benzodiazepine Tapering
A structured, practical course built on the newly released 2025 ASAM Clinical Practice Guideline — for clinicians supporting patients on long-term benzodiazepines, navigating difficult withdrawal, and making high-stakes risk–benefit decisions.
4 Sessions ~2 Hours 2025 ASAM Guideline Academy Members Only
4
Focused Sessions
2 hrs
Total Runtime
2025
ASAM Guideline-Based
About This Course

Join us for a structured course designed to equip you with the most current, evidence-based approaches to benzodiazepine tapering. Whether you are supporting patients with long-term benzodiazepine use, managing challenging withdrawal symptoms, or weighing risk–benefit decisions, this course delivers the framework and clarity you need to taper confidently.

Each session is concise and clinically oriented — translating the 2025 ASAM guideline into decisions you can apply at the next visit. Start with the welcome introduction, then move through the four core sessions in order.

What You'll Cover
1
Clinical Foundations of BZD Tapering
Foundational principles & decision-making — tapering vs. discontinuation, assessing dependence status
35 min
2
Designing & Monitoring the Taper
Building a patient-specific schedule, dose conversions, pace & monitoring
30 min
3
Adjunctive Strategies & Complication Management
Supportive pharmacology, managing setbacks & difficult symptoms
15 min
4
Special Populations & Complex Clinical Scenarios
Older adults, co-occurring conditions, polypharmacy & high-risk cases
35 min
Tapering vs. Discontinuation: Assess Dependence Status
A slide from the course
Course slide outlining how to assess dependence status in patients on chronic benzodiazepine therapy
Who Should Enroll
Psychiatrists & Primary Care Physicians
Nurse Practitioners & Physician Assistants
Pharmacists
Any clinician involved in BZD prescribing or tapering

Included with Academy Membership

This course is part of your Academy Membership — alongside 470+ clinical chapters, Journal Club, Clinical Case Discussions, the CME Academy, and the Academy Network community.

Join the Academy → See Pricing Plans

TABLE OF CONTENT:

Evidence Based Benzodiazepine Tapering: 2025 ASAM Guidelines

Introduction: Welcome to Course

Foundational Principles & Decision-Making (35 min)

Designing & Monitoring the Taper (30 min)

Adjunctive Strategies & Complication Management (15 min)

Special Populations & Complex Clinical Scenarios (35 min)

Share

Responses

Your email address will not be published. Required fields are marked *

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .